| Financial Year |
March 31 2023 |
| Monetary Funds |
835,335,587.72 |
| Held-for-trading Financial Assets |
53,288,607.04 |
| Notes Receivable |
218,445,583.72 |
| Accounts Receivable |
404,412,556.26 |
| Advances to Suppliers |
33,458,110.51 |
| Other Receivables |
13,607,347.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
136,188,959.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,777,234.16 |
| Total Current Assets |
2,179,279,860.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
16,711,649.02 |
| Fixed Assetes |
421,505,548.08 |
| Under-construction Projects |
24,473,279.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
27,106,028.56 |
| R&D expenses |
-- |
| Goodwill |
23,459,884.67 |
| Long-Term Deferred and Prepaid Expenses |
1,968,427.35 |
| Deferred Income Tax Assets |
19,054,812.95 |
| Other Non-Current Assets |
24,766,716.13 |
| Sub-Total of Non-Current Assets |
590,159,189.32 |
| Total Assets |
2,769,439,049.78 |
| Short-Term Loans |
345,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
243,828,210.91 |
| Accounts Payable |
231,903,298.40 |
| Accounts Received In Advance |
2,223,417.77 |
| Employee Compensation Payable |
7,202,723.84 |
| Taxes Payable |
9,961,193.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,855,761.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
17,460,749.53 |
| Sub-Total of Current Liabilities |
930,774,344.42 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,506,616.69 |
| Deferred Income Tax Liabilities |
493,291.06 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
15,593,075.42 |
| Total Liabilities |
946,367,419.84 |
| Paid-In Capital(Or Share Stock) |
132,419,000.00 |
| Capital Surplus |
882,023,163.12 |
| Surplus Reserve |
59,943,224.69 |
| LESS:Treasury Stock |
22,520,224.00 |
| Undistributed Profits |
678,990,008.22 |
| Minority Stockholder's Interest |
92,216,457.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,730,855,172.03 |
| Owner's Equity（Stockholder's Equity） |
1,823,071,629.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,769,439,049.78 |
